We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this ...

Last year marked the first time in Pfizer’s 175-year history that the drugmaker shelled out the requisite millions for ...

ZUG, Switzerland and BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical ...

Graham G. Walmsley, a director at Akero Therapeutics, Inc. (NASDAQ:AKRO), recently acquired a significant amount of the company's common stock. According to a recent SEC filing, Walmsley purchased 200 ...

Musk’s arrival at the social platform has raised questions for users, which includes pharma companies who use Twitter ... after an account using its name and logo sent out a Tweet, which read ...

From Ben Affleck's DunKings to David Beckham and his long-lost twin Dave (played by Matt Damon) and all the pop star ...

The "Crown" logo, PanOxyl and Blue Lizard are registered trademarks of Crown Laboratories, Inc. SkinPen and StriVectin are registered trademarks of Bellus Medical, LLC and StriVectin Operating Company ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

In a report released today, Elyse Shapiro from Canaccord Genuity maintained a Buy rating on Mayne Pharma Group (MAYNF – Research Report), with ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

Novo Nordisk (NVO), a pharmaceutical company, isn’t too worried about the U.S. government’s plan to negotiate prices for its ...